ISOTRETINOIN Mepha caps moll 40 mg 30 pce

7680559720173 CH-55972 D10BA01 10.02.0.

Reimbursement limitations:

TRETINAC

Formes graves de l'acné, résistantes à la thérapie.

ISOTRETINOIN Mepha caps moll 40 mg 30 pce
ISOTRETINOIN Mepha caps moll 40 mg 30 pce
ISOTRETINOIN Mepha caps moll 40 mg 30 pce
1 / 3
google

Details

Product number
5597203
CPT
-
Packaging group
30
Unit
Kapsel(n)
Composition
isotretinoinum 40 mg, sojae oleum raffinatum 198.7 mg, int-rac-alpha-tocopherolum, dinatrii edetas corresp. natrium 0.12 mg, E 320, sojae oleum partim hydrogenatum 45.65 mg, sojae oleum hydrogenatum 21 mg, cera flava, Kapselhülle: gelatina, glycerolum, sorbitolum liquidum non cristallisabile 23.75 mg, aqua purificata, E 110 65 µg, E 171, pro capsula.

Articles (1)

Isotretinoin-Mepha 40 mg, Weichkapseln
Weichkapseln
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
22/08/2023
Patient information leaflet
Français
22/08/2023
Patient information leaflet
Italien
22/08/2023
Professional SmPC
Allemand
22/08/2023
Professional SmPC
Français
22/08/2023
Professional SmPC
Italien
22/08/2023

Detailed composition

Substance Quantity Type Category
(N/A)
40.0 MG Substance Wirkstoff (Principe actif)
(N/A)
198.7 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.12 MG Substance HBESI
(N/A)
- Substance ANTOX
(N/A)
45.65 MG Substance HBESI
(N/A)
21.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
23.75 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
65.0 UG Substance HBESI
(N/A)
- Substance FNIDK

Reimbursement information

Public price
CHF 59.00
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/07/2007

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
55972
Drug name
Isotretinoin-Mepha, Weichkapseln
Galenic form
KAPWE
ATC Code
D10BA01
Authorization status
Z
Dispensation category
A
First authorization
18/09/2002
Authorization expiration date
31/12/9999
IT number
10.02.0.
Domain
Human medicine
Field of application
Schwere therapieresistente Formen von Akne

Packaging details

Description (FR)
ISOTRETINOIN Mepha caps moll 40 mg 30 pce
Description (DE)
ISOTRETINOIN Mepha Weichkaps 40 mg 30 Stk
Market launch
12/04/2007
Narcotic (BTM)
No

Other packaging sizes

ISOTRETINOIN Mepha caps moll 10 mg 30 pce
30 KAP
View
ISOTRETINOIN Mepha caps moll 10 mg 100 pce
100 KAP
View
ISOTRETINOIN Mepha caps moll 20 mg 30 pce
30 KAP
View
ISOTRETINOIN Mepha caps moll 20 mg 100 pce
100 KAP
View
ISOTRETINOIN Mepha caps moll 40 mg 100 pce
100 KAP
View
ISOTRETINOIN Mepha caps moll 5 mg 30 pce
30 KAP
View
ISOTRETINOIN Mepha caps moll 5 mg 100 pce
100 KAP
View